HeartBeam Analyst Ratings
BenzingaMar 25 11:06 ET
Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target
BenzingaNov 16, 2023 12:16 ET
HeartBeam Analyst Ratings
BenzingaNov 16, 2023 12:12 ET
Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target
BenzingaAug 24, 2023 08:53 ET
HeartBeam Analyst Ratings
BenzingaAug 24, 2023 08:52 ET
Analysts Offer Insights on Healthcare Companies: Emergent Biosolutions (EBS) and HeartBeam (BEAT)
TipRanksMay 19, 2023 12:30 ET
HeartBeam Analyst Ratings
Benzinga Analyst RatingsDec 2, 2022 08:08 ET
Dawson James Initiates Coverage on HeartBeam With Buy Rating, $12 Price Target
MT NewswiresJul 25, 2022 12:42 ET
No Data
No Data